🔎 Trials Near Me

Početna › Kronična limfocitna leukemija › Florida › Miami

Kliničke studije za Kronična limfocitna leukemija u gradu Miami, FL

9 studija za Kronična limfocitna leukemija traži sudionike na lokacijama u gradu Miami i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

U tijeku regrutacijaFaza 3
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Od 65 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07321652

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

U tijeku regrutacijaFaza 1/2
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT05006716

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

U tijeku regrutacijaFaza 3
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07277231

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

U tijeku regrutacijaFaza 3
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06973187

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

U tijeku regrutacijaFaza 1
  • University of Miami, Miami
Od 18 godina i više · Oba spola · Ažurirano 2. srp 2026. · NCT05131022

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

U tijeku regrutacijaFaza 2
  • University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 19. svi 2026. · NCT06588478

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

U tijeku regrutacijaFaza 2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 13. ožu 2026. · NCT07218510

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

U tijeku regrutacijaFaza 4
  • Sylvester Comprehensive Cancer Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 2. ožu 2026. · NCT06876662

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

U tijeku regrutacijaFaza 4
  • Sylvester Comprehensive Cancer Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 2. ožu 2026. · NCT06876649

Studije za Kronična limfocitna leukemija u drugim gradovima

Ostale studije u gradu Miami

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.